 |
|
|
| |
Nucleos(t)ide Analogue (NA) Therapy for Persons in the Immunotolerant Phase of CHB Is Associated With Significant Declines in HBeAg and HBsAg Levels
|
| |
| |
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Gillian Rosenberg,1 Julianne Bayliss,1 Anuj Gaggar,2 Kathryn Kitrinos,2 Mani Subramanian,2 Ed Gane,3 Henry LY Chan,4 Rachel Hammond,1 Scott Bowden,1 Peter Revill,1 Stephen Locarnini,1 Alexander Thompson5
1Victorian Infectious Diseases Reference Laboratory (VIDRL), North Melbourne, Victoria, Australia; 2Gilead Sciences, Inc., Foster City, California, USA; 3Auckland City Hospital, Grafton, Auckland, New Zealand; 4Chinese University of Hong Kong SAR; 5St Vincent's Hospital, Fitzroy, Victoria, Australia
|
| |
|
|
|
|
|
